Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly

We report the generation and preclinical characterization of 3 hypoallergenic rBet v 1 derivatives with suitable properties for immunotherapy of birch pollen allergy.